Medtronic plc (NYSE:MDT) will release its first earnings report before the opening bell on Tuesday, Sept. 1.
Analysts expect the Galway, Ireland-based company to report quarterly earnings of $1.39 per share, up from $1.26 per share in the year-ago period. The consensus estimate for Medtronic’s quarterly revenue is $9.54 billion. It reported $8.54 billion last year, according to Benzinga Pro.
On Aug. 20, the company’s board of directors declared a cash dividend for the second quarter of 72 cents per ordinary share.
Medtronic shares fell 2.2% to close at $89.97 on Thursday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.
- Needham analyst Mike Matson maintained a Buy rating and boosted the price target from $101 to $114 on Aug. 27, 2026. This analyst has an accuracy rate of 58%.
- BTIG analyst Ryan Zimmerman maintained a Buy rating with a price target of $91 on Aug. 18, 2026. This analyst has an accuracy rate of 65%.
- UBS analyst Priya Sachdeva upgraded the stock from Neutral to Buy and raised the price target from $85 to $100 on July 28, 2026. This analyst has an accuracy rate of 67%.
- TD Cowen analyst Joshua Jennings maintained a Buy rating and cut the price target from $119 to $100 on July 10, 2026. This analyst has an accuracy rate of 57%.
- Evercore ISI Group analyst Vijay Kumar maintained an Outperform rating and cut the price target from $106 to $105 on July 6, 2026. This analyst has an accuracy rate of 64%.
Considering buying MDT stock? Here’s what analysts think:
Photo via Shutterstock